WilmerHale Represents PerkinElmer in $800M Offering of Senior Notes

WilmerHale Represents PerkinElmer in $800M Offering of Senior Notes

Client News

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.

On March 4, 2021, PerkinElmer, a global leader committed to innovating for a healthier world, announced its offering of $400 million of 2.550% Senior Notes due 2031 and $400 million of 3.625% Senior Notes due 2051. The company intends to use the proceeds from the offering to fund a portion of the purchase price to acquire Oxford Immunotec Global PLC, with the remainder to repay at maturity a portion of its €300 million aggregate principal amount of 0.600% senior notes due 2021. The offering priced on March 4, 2021 and closed on March 8, 2021. The joint book-running managers for the offering were J.P. Morgan Securities LLC, BofA Securities, Inc. and Wells Fargo Securities, LLC.

The WilmerHale team representing PerkinElmer consisted of Erika Robinson, Justin Ochs, Julie Hogan Rodgers, Sean Linnehan, Chris Gravallese and Mark Devine.


Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel